The two GPER-positive breast cancer cell lines MCF-7 (ER + , PR + , Her2 + , GPER+45) and HS578T (ER-, PR-, Her2-, GPER+45) were used as model systems (control: ERα17p). This evidence concerns the gene ERBB2 and breast carcinoma.